Chemistry / M2 Pharma, "Clinical Study of CanSino COVID-19 Vaccine as Clinical Contract Research Organization."

Pers / media: Vakinhoudelijk commentaar

Periode1 mrt 2021

Media-aandacht

1

Media-aandacht